Supplemental Table S1. Efficacy of JAK1 inhibitors and dupilumab.
收藏Mendeley Data2026-04-09 收录
下载链接：
https://data.mendeley.com/datasets/6436c9h74p
下载链接
链接失效反馈官方服务：
资源简介：
EASI, Eczema Area and Severity Index; EASI-50/75: improvement of at least 50%/75% in the EASI score compared to baseline; IGA, Investigator's Global Assessment; IQR, interquartile range; JAK, Janus kinase 1; SCORAD, SCORing Atopic Dermatitis; WP-NRS, Weekly Peak Pruritus Numeric Rating Scale.
Continuous variables are presented as median [IQR], and categorical variables are presented as counts (percentages). Data missing: 1 n=14; 2 n=7.
EASI为湿疹面积和严重程度指数（Eczema Area and Severity Index, EASI）；EASI-50/75指较基线EASI评分至少改善50%/75%；IGA为研究者整体评估（Investigator's Global Assessment, IGA）；IQR为四分位距（interquartile range, IQR）；JAK为贾纳斯激酶1（Janus kinase 1, JAK）；SCORAD为特应性皮炎评分（SCORing Atopic Dermatitis, SCORAD）；WP-NRS为每周峰值瘙痒数字评分量表（Weekly Peak Pruritus Numeric Rating Scale, WP-NRS）。连续变量以中位数[四分位距]形式呈现，分类变量以例数（百分比）形式呈现。数据缺失情况：1项（n=14）、2项（n=7）。
